FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000 IGF-1

MDR report key: 2840794 · Received November 20, 2012

Report

Report Number
2432235-2012-00386
Event Type
Malfunction
Date Received
November 20, 2012
Date of Event
August 21, 2012
Report Date
October 22, 2012
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS
Product Code
CFL
PMA / PMN Number
EXEMPT
Removal / Correction Number
2432235-11/28/2012-007-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
HEALTH PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

(B)(4) 2012: THE CORRECTIONS AND REMOVAL REPORT (CRR) WAS FILED WITH THE FDA ON NOVEMBER 28, 2012. THE CRR NUMBER IS 2432235-11/28/2012-007-C.

Additional Manufacturer Narrative · 1

THE CAUSE OF THE FALSELY ELEVATED IGF-1 RESULTS IS UNKNOWN. AN URGENT FIELD SAFETY NOTICE (UFSN), UFSN 4005 - "IMMULITE / IMMULITE 1000 / IMMULITE 2000 / IMMULITE 2000 XPI ALL IMMULITE PLATFORMS FOR IGF-I SHIFT IN PATIENT MEDIANS AND SUPPLY DISRUPTION" WAS SENT TO CUSTOMERS IN NOVEMBER 2012. SIEMENS IS INVESTIGATING THIS ISSUE.

Description of Event or Problem · 1

A POSITIVE BIAS HAS BEEN OBSERVED IN PATIENT RESULTS FOR INSULIN-LIKE GROWTH FACTOR (IGF-1) OBTAINED ON AN IMMULITE 2000 XPI INSTRUMENT. A PATHOLOGIST QUESTIONED THE HIGH IGF-1 VALUES AFTER REVIEWING ALL PATIENT RESULTS FROM 2008 TO 2012. THERE WERE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT IGF-1 RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 IMMULITE 2000 IGF-1 IMMULITE 2000 XPI CFL SIEMENS HEALTHCARE DIAGNOSTICS IMMULITE 2000 IGF-1

Patients

Seq Age Sex Outcome Treatment
1 Unknown